Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.

Radkay LA, Chiosea SI, Seethala RR, Hodak SP, LeBeau SO, Yip L, McCoy KL, Carty SE, Schoedel KE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2014 Dec;122(12):873-82. doi: 10.1002/cncy.21474. Epub 2014 Aug 12.

PMID:
25132659
2.

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view.

Ohori NP, Wolfe J, Hodak SP, LeBeau SO, Yip L, Carty SE, Duvvuri U, Schoedel KE, Nikiforova MN, Nikiforov YE.

Cancer Cytopathol. 2013 Dec;121(12):718-28. doi: 10.1002/cncy.21333. Epub 2013 Jul 23. Erratum in: Cancer Cytopathol. 2014 Dec;122(12):921.

PMID:
23881852
3.

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.

Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH, Krasinskas AM, Ohori NP, Schoedel KE, Navina S, Mantha GS, Pai RK, Singhi AD.

Mod Pathol. 2013 Nov;26(11):1478-87. doi: 10.1038/modpathol.2013.91. Epub 2013 Jun 7.

4.

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.

Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.

PMID:
22887810
6.

Selective screening for nongynecologic cytology specimens: modifying the screening process for improved efficiency and practice.

Marks-Jones DA, Sutkowski BA, Schoedel KE, Ohori NP.

Diagn Cytopathol. 2011 Oct;39(10):717-22. doi: 10.1002/dc.21449. Epub 2010 Nov 2.

PMID:
21919214
7.

Thyroid cytology: challenges in the pursuit of low-grade malignancies.

Ohori NP, Schoedel KE.

Radiol Clin North Am. 2011 May;49(3):435-51, v-vi. doi: 10.1016/j.rcl.2011.02.005. Review.

PMID:
21569903
8.

DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma.

Fasanella KE, Krasinskas A, Schoedel KE, Sasatomi E, Slivka A, Whitcomb DC, Sanders M, Nodit L, Raab S, McGrath KM, Ohori NP, Khalid A.

Pancreatology. 2010;10(4):429-33. doi: 10.1159/000318807. Epub 2010 Aug 19.

PMID:
20720444
9.

Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".

Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE.

Cancer Cytopathol. 2010 Feb 25;118(1):17-23. doi: 10.1002/cncy.20063.

PMID:
20099311
10.

EUS-guided FNA diagnosis of primary splenic lymphoma.

El Hajj II, Khalid A, Schoedel KE, Abu-Elmagd KM, McGrath KM, Fasanella KE.

Gastrointest Endosc. 2009 Mar;69(3 Pt 1):585-8. doi: 10.1016/j.gie.2008.04.058. Epub 2008 Nov 13. No abstract available.

PMID:
19012888
11.

Ultrasound-guided biopsy of the thyroid: a comparison of technique with respect to diagnostic accuracy.

Schoedel KE, Tublin ME, Pealer K, Ohori NP.

Diagn Cytopathol. 2008 Nov;36(11):787-9. doi: 10.1002/dc.20896.

PMID:
18831012
12.

Endoscopic ultrasound-guided fine needle aspirate microsatellite loss analysis and pancreatic endocrine tumor outcome.

Nodit L, McGrath KM, Zahid M, Jani N, Schoedel KE, Ohori NP, Carty S, Finkelstein S, Khalid A.

Clin Gastroenterol Hepatol. 2006 Dec;4(12):1474-8. Epub 2006 Sep 25.

PMID:
16996803
13.
14.

Clonorchis sinensis-associated cholangiocarcinoma: a case report and review of the literature.

Papachristou GI, Schoedel KE, Ramanathan R, Rabinovitz M.

Dig Dis Sci. 2005 Nov;50(11):2159-62. Review. No abstract available.

PMID:
16240232
15.
16.

HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.

Schoedel KE, Tyner VZ, Kim TH, Michalopoulos GK, Mars WM.

Mod Pathol. 2003 Jan;16(1):14-21.

18.

Response to baloch and liVolsi

Ohori NP, Schoedel KE.

Diagn Cytopathol. 1999 Oct;21(4):303. No abstract available.

PMID:
10495330
20.

An S100 negative granular cell tumor with malignant potential: report of a case.

Schoedel KE, Bastacky S, Silverman A.

J Am Acad Dermatol. 1998 Nov;39(5 Pt 2):894-8.

PMID:
9810925
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk